JPRN-UMIN000018081已完成未知
Tolvaptan and Conventional Treatment for Acute Decompensated Heart Failure - Tolvaptan and Conventional Treatment for Acute Decompensated Heart Failure
agano Matsushiro General Hospital0 个研究点目标入组 60 人开始时间: 2015年6月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional,observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with hypersensitivity to Tolvaptan and the analogous compounds 2. Hemodialysis 3. Disability to appeal thirsty 4. Serum sodium > 145 mEq/L at allocation 5. Pregnancy 6. Acute coronary syndrome 7. Patients who attending physicians consider to be inappropriate due to other reasons mentioned above
研究者
相似试验
招募中
4 期
Efficacy and safety of tolvaptan in Acute Heart FailureCTRI/2013/05/003643SRM Medical College Hospital Research Centre50
招募中
不适用
Comparison of Tolvaptan and Carperitide in acute decompensated heart failureAcute decompensated heart failureJPRN-UMIN000012317Anjo Kosei Hospital100
招募中
不适用
Effect of tolvaptan prodrug in patients with acute heart failure who continue oral tolvaptan therapyAcute heart failureJPRN-UMIN000047646Izumi City General Hospital50
已完成
不适用
Comparison of Tolvaptan treatment and conventional treatment in elderly acute heart failure.Acute decompensated heart failureJPRN-UMIN000028039Iiyama redcross hospital60
终止
4 期
Tolvaptan for Advanced or Refractory Heart FailureHeart FailureHyponatremiaNCT02959411University of Calgary9